Astellas Pharma Correlations
| ALPMY Stock | USD 10.29 0.12 1.18% |
The current 90-days correlation between Astellas Pharma and SoFi Technologies is -0.41 (i.e., Very good diversification). The correlation of Astellas Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Astellas |
The ability to find closely correlated positions to Astellas Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Astellas Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Astellas Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Astellas Pharma to buy it.
Moving together with Astellas Pink Sheet
| 0.85 | LLY | Eli Lilly Sell-off Trend | PairCorr |
| 0.83 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.83 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.68 | RHHBF | Roche Holding AG | PairCorr |
| 0.83 | RHHBY | Roche Holding | PairCorr |
| 0.86 | RHHVF | Roche Holding AG | PairCorr |
| 0.85 | AZNCF | AstraZeneca PLC | PairCorr |
| 0.87 | NVS | Novartis AG ADR | PairCorr |
| 0.85 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.86 | NVSEF | Novartis AG | PairCorr |
| 0.66 | EC | Ecopetrol SA ADR | PairCorr |
| 0.69 | PKX | POSCO Holdings | PairCorr |
Moving against Astellas Pink Sheet
| 0.74 | PTAIF | PT Astra International | PairCorr |
| 0.69 | SSNLF | Samsung Electronics | PairCorr |
| 0.91 | IONQ | IONQ Inc | PairCorr |
| 0.88 | ADSK | Autodesk | PairCorr |
| 0.87 | TSLA | Tesla Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.84 | ARCC | Ares Capital | PairCorr |
| 0.84 | SYM | Symbotic | PairCorr |
| 0.8 | RIOT | Riot Blockchain Buyout Trend | PairCorr |
| 0.79 | GABC | German American Bancorp | PairCorr |
| 0.78 | KRKNF | Kraken Robotics | PairCorr |
| 0.78 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.77 | NWS | News Corp B | PairCorr |
| 0.68 | K | Kellanova | PairCorr |
| 0.65 | TBBK | Bancorp Normal Trading | PairCorr |
| 0.37 | JBLU | JetBlue Airways Corp | PairCorr |
| 0.35 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.33 | PIFMY | Indofood Sukses Makmur | PairCorr |
| 0.9 | VST | Vistra Energy Corp Downward Rally | PairCorr |
| 0.89 | BX | Blackstone Group Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.88 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
| 0.88 | BSTZ | BlackRock Science | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Astellas Pink Sheet performing well and Astellas Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Astellas Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OPHLY | 1.20 | (0.43) | 0.00 | (9.84) | 0.00 | 1.90 | 10.36 | |||
| GRFS | 1.95 | (0.15) | 0.00 | (0.19) | 0.00 | 5.06 | 17.76 | |||
| PFE | 1.03 | (0.19) | 0.00 | (0.35) | 0.00 | 2.17 | 8.17 | |||
| NCL | 5.42 | 0.39 | 0.05 | 0.27 | 6.10 | 16.67 | 75.00 | |||
| MSFT | 0.92 | (0.05) | (0.05) | 0.05 | 1.49 | 2.09 | 8.19 | |||
| PLTR | 2.56 | 0.99 | 0.47 | 0.59 | 1.44 | 8.61 | 30.33 | |||
| SOFI | 2.53 | 1.12 | 0.41 | (21.94) | 1.81 | 7.21 | 17.87 | |||
| LUMN | 3.69 | 0.27 | 0.12 | 0.20 | 3.92 | 9.55 | 27.32 | |||
| AKTS | 6.82 | 0.79 | 0.06 | (0.52) | 7.89 | 14.87 | 36.03 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Astellas Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Astellas Pharma Corporate Management
| Minoru Kikuoka | CFO Officer | Profile | |
| Naoki BSc | Chief VP | Profile | |
| Kenji Yasukawa | Senior Executive Officer, Manager of Vaccine Business Promotion Office | Profile | |
| Stig Ogata | VP Communications | Profile | |
| Katsuyoshi Sugita | Chief Officer | Profile |